| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Grațiela Grădișteanu Pîrcălăbioru | Q57966279 |
| Carmen Curutiu | Q92942026 | ||
| Lia-Mara Dițu | Q99215143 | ||
| Alina Maria Holban | Q108123951 | ||
| Irina Gheorghe | Q108419610 | ||
| Veronica Lazăr | Q108422666 | ||
| Ariana Picu | Q108422683 | ||
| Laura Petcu | Q108422685 | ||
| Mariana Carmen Chifiriuc | Q42823400 | ||
| P2860 | cites work | Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. | Q53404036 |
| Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. | Q54182323 | ||
| Probiotic Bacteria and their Supernatants Protect Enterocyte Cell Lines from Enteroinvasive Escherichia coli (EIEC) Invasion. | Q54204797 | ||
| Streptococcus anginosus infection in oral cancer and its infection route. | Q54664139 | ||
| Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. | Q54766730 | ||
| Environment dominates over host genetics in shaping human gut microbiota | Q59069853 | ||
| Gut Dysbiosis Associated With Hepatitis C Virus Infection | Q59349057 | ||
| Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis | Q21128781 | ||
| The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects | Q21245477 | ||
| Microbial biofilms: from ecology to molecular genetics | Q21999032 | ||
| Angiogenins: a new class of microbicidal proteins involved in innate immunity | Q24293270 | ||
| Effects of short chain fatty acids on gut morphology and function | Q24540325 | ||
| Dietary fiber intake and mortality in the NIH-AARP diet and health study | Q24603964 | ||
| Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut | Q24620817 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses | Q24630221 | ||
| Symbiotic bacteria direct expression of an intestinal bactericidal lectin | Q24644003 | ||
| The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity | Q24645048 | ||
| The risk of colorectal cancer in ulcerative colitis: a meta-analysis | Q24669747 | ||
| Antibiotic use and its consequences for the normal microbiome | Q26749112 | ||
| Pathogenic role of the gut microbiota in gastrointestinal diseases | Q26749878 | ||
| Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases | Q26784194 | ||
| Bacterial quorum sensing: its role in virulence and possibilities for its control | Q26830110 | ||
| The role of gut microbiota in immune homeostasis and autoimmunity | Q26860722 | ||
| The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes | Q27000404 | ||
| Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection | Q27009228 | ||
| Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis | Q27012868 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes | Q71493611 | ||
| Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function | Q73336781 | ||
| Understanding type 1 diabetes through genetics: advances and prospects | Q82065036 | ||
| A role of hydrogen peroxide producing commensal bacteria present in colon of adolescents with inflammatory bowel disease in perpetuation of the inflammatory process | Q83180526 | ||
| Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer | Q84093730 | ||
| The human gut microbiota and undernutrition | Q84313779 | ||
| Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization | Q88098315 | ||
| The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy | Q88318275 | ||
| Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes | Q35661927 | ||
| Cell-to-cell signaling in intestinal pathogens. | Q35728492 | ||
| A comprehensive repertoire of prokaryotic species identified in human beings | Q35756736 | ||
| High frequencies of antibiotic resistance genes in infants' meconium and early fecal samples | Q35768509 | ||
| Robust species taxonomy assignment algorithm for 16S rRNA NGS reads: application to oral carcinoma samples. | Q35794960 | ||
| Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy | Q35833912 | ||
| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota | Q35833921 | ||
| Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease | Q35892249 | ||
| Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children | Q35904758 | ||
| Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis | Q35912366 | ||
| The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. | Q35973636 | ||
| Development and maintenance of intestinal regulatory T cells | Q35992122 | ||
| Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease | Q36035194 | ||
| Diet-microbiota interactions as moderators of human metabolism | Q36069065 | ||
| The microbiome and innate immunity | Q36069070 | ||
| The late phase of sepsis is characterized by an increased microbiological burden and death rate | Q36070469 | ||
| Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study | Q36081669 | ||
| Antibiotics as deep modulators of gut microbiota: between good and evil. | Q36105508 | ||
| Interaction of mucosal microbiota with the innate immune system. | Q36161518 | ||
| Role of intestinal microbiota and metabolites on gut homeostasis and human diseases | Q36243299 | ||
| Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. | Q36308832 | ||
| Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. | Q36313548 | ||
| The function of immunoglobulin A in immunity | Q36346119 | ||
| Fecal microbiota composition differs between children with β-cell autoimmunity and those without | Q36720600 | ||
| Helicobacter Pylori associated global gastric cancer burden. | Q37125644 | ||
| Role of the Gut Microbiome in Modulating Arthritis Progression in Mice | Q37145101 | ||
| Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin | Q37164254 | ||
| Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer? | Q37167416 | ||
| Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice | Q37191056 | ||
| Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. | Q37223806 | ||
| Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. | Q37258771 | ||
| The effect of neurohormonal factors, epigenetic factors, and gut microbiota on risk of obesity. | Q37293511 | ||
| Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis | Q37421142 | ||
| Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota | Q28069635 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer | Q28592907 | ||
| Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome | Q28829489 | ||
| Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice | Q29614457 | ||
| NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis | Q29616155 | ||
| Microbial culturomics: paradigm shift in the human gut microbiome study | Q29616597 | ||
| Anticancer activities of histone deacetylase inhibitors | Q29616624 | ||
| Gut Microbiota in Health and Disease | Q29616812 | ||
| The impact of the gut microbiota on human health: an integrative view | Q29617446 | ||
| Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma | Q30528676 | ||
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | Q31144277 | ||
| Genetic susceptibility to type 1 diabetes mellitus in humans. | Q33247589 | ||
| Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin | Q33357682 | ||
| Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls | Q33416358 | ||
| Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome | Q33547430 | ||
| Inflammatory bowel disease: an expanding global health problem | Q33608406 | ||
| Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. | Q33651733 | ||
| Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview | Q33665341 | ||
| Changes in abundance of oral microbiota associated with oral cancer | Q33700542 | ||
| Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease | Q33738097 | ||
| Role of the microbiota in immunity and inflammation | Q33752553 | ||
| Microbial diversity in saliva of oral squamous cell carcinoma | Q33785278 | ||
| Dairy Propionibacteria: Versatile Probiotics. | Q33845397 | ||
| Diet-induced alterations in gut microflora contribute to lethal pulmonary damage in TLR2/TLR4-deficient mice | Q33921242 | ||
| Microbes in gastrointestinal health and disease | Q33943525 | ||
| Pseudomonas aeruginosa quorum-sensing molecule homoserine lactone modulates inflammatory signaling through PERK and eI-F2α | Q33964119 | ||
| The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin | Q33994813 | ||
| Probiotics-host communication: Modulation of signaling pathways in the intestine | Q34018028 | ||
| Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women | Q34027538 | ||
| Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes | Q34063601 | ||
| Gut microbiota promote hematopoiesis to control bacterial infection | Q34089573 | ||
| The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice | Q34193512 | ||
| Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. | Q41450612 | ||
| Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients | Q41693862 | ||
| Variations in oral microbiota associated with oral cancer | Q41718083 | ||
| Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway | Q41828839 | ||
| The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. | Q42037672 | ||
| Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. | Q42125930 | ||
| Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. | Q42673580 | ||
| Effects of multispecies probiotic combination on helicobacter pylori infection in vitro. | Q42751573 | ||
| Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure | Q42970730 | ||
| Intestinal bacterial beta-glucuronidase activity of patients with colon cancer | Q43856741 | ||
| Colonization dynamics of ampicillin-resistant Escherichia coli in the infantile colonic microbiota | Q44429377 | ||
| High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption | Q44805923 | ||
| The Th17 cell population and the immune homeostasis of the gastrointestinal tract. | Q45132459 | ||
| Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains. | Q45977056 | ||
| Gastric microbiota: tracing the culprit | Q46258930 | ||
| Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota | Q46268793 | ||
| Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes | Q46593907 | ||
| Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates | Q46919709 | ||
| Compromised gut microbiota networks in children with anti-islet cell autoimmunity | Q46922105 | ||
| Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. | Q47447695 | ||
| A molecular analysis of the bacteria present within oral squamous cell carcinoma | Q48076351 | ||
| The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. | Q48306869 | ||
| The microflora associated with human oral carcinomas | Q48351090 | ||
| Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors | Q48373246 | ||
| Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells | Q49339623 | ||
| Effect of Propionibacterium freudenreichii on Salmonella multiplication, motility, and association with avian epithelial cells1. | Q49960932 | ||
| Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet. | Q50795525 | ||
| Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. | Q51358057 | ||
| The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. | Q37436205 | ||
| Probiotics and gastrointestinal disease: successes, problems and future prospects | Q37460752 | ||
| Enteric defensins are essential regulators of intestinal microbial ecology | Q37483232 | ||
| Quorum sensing and social networking in the microbial world. | Q37578893 | ||
| 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment | Q37588284 | ||
| The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin | Q37662888 | ||
| Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans | Q37689340 | ||
| Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery | Q37702393 | ||
| Influence of diet on the gut microbiome and implications for human health. | Q37742351 | ||
| Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. | Q37851072 | ||
| Medical significance and new therapeutical strategies for biofilm associated infections | Q37857206 | ||
| Quorum sensing in biofilms--how to destroy the bacterial citadels or their cohesion/power? | Q37865843 | ||
| Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. | Q37866633 | ||
| Is the origin of type 1 diabetes in the gut? | Q37980043 | ||
| Bacteria as vitamin suppliers to their host: a gut microbiota perspective | Q38039782 | ||
| Advances in management of type 1 diabetes mellitus | Q38260399 | ||
| Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts | Q38650368 | ||
| Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice | Q38719297 | ||
| Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System | Q38772593 | ||
| When pathogenic bacteria meet the intestinal microbiota. | Q38817334 | ||
| Dairy propionibacteria as probiotics: recent evidences. | Q38827405 | ||
| Screening of Propionibacterium spp. for potential probiotic properties | Q38863607 | ||
| The Enterobacterial Genotoxins: Cytolethal Distending Toxin and Colibactin | Q38897671 | ||
| Carcinogenesis mechanisms of Fusobacterium nucleatum. | Q39022292 | ||
| Mammalian Lipopolysaccharide Receptors Incorporated into the Retroviral Envelope Augment Virus Transmission. | Q39097992 | ||
| Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy | Q39130451 | ||
| Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. | Q39135685 | ||
| The Gut Microbiota and Alzheimer's Disease | Q39217126 | ||
| Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study | Q39328374 | ||
| One year in review 2017: systemic lupus erythematosus | Q39443539 | ||
| The growth response of Escherichia coli to neurotransmitters and related catecholamine drugs requires a functional enterobactin biosynthesis and uptake system | Q39663078 | ||
| Anaerobic Degradation of Flavonoids by Clostridium orbiscindens | Q39913608 | ||
| The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field. | Q40075191 | ||
| Immunomodulatory effects of Pseudomonas aeruginosa quorum sensing small molecule probes on mammalian macrophages | Q40249339 | ||
| Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab | Q40262479 | ||
| Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. | Q40398677 | ||
| Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function | Q41001928 | ||
| Hallmarks of response to immune checkpoint blockade | Q41078811 | ||
| Pseudomonas aeruginosa Homoserine lactone activates store-operated cAMP and cystic fibrosis transmembrane regulator-dependent Cl- secretion by human airway epithelia | Q34251347 | ||
| Antibiotics and the gut microbiota | Q34311624 | ||
| Intestinal dysbiosis associated with systemic lupus erythematosus | Q34334692 | ||
| Microbes, immunoregulation, and the gut. | Q34394387 | ||
| The gut microbiota, bacterial metabolites and colorectal cancer | Q34437334 | ||
| The role of commensal bacteria in the regulation of sensitization to food allergens | Q34437865 | ||
| Effect of breast and formula feeding on gut microbiota shaping in newborns | Q34453923 | ||
| Host microbiota constantly control maturation and function of microglia in the CNS. | Q34478756 | ||
| Metabolism of cholesterol and bile acids by the gut microbiota. | Q34533691 | ||
| Early development of the gut microbiota and immune health | Q34569160 | ||
| Dynamics of gut microbiota in autoimmune lupus | Q34595444 | ||
| The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota | Q34647328 | ||
| Inter-kingdom signalling: communication between bacteria and their hosts | Q34655655 | ||
| Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury | Q34746651 | ||
| Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease | Q34791372 | ||
| AI-2 signalling is induced by acidic shock in probiotic strains of Lactobacillus spp. | Q35002477 | ||
| The microbiome and cancer | Q35019302 | ||
| Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface | Q35021987 | ||
| Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice | Q35026610 | ||
| Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. | Q35050169 | ||
| Salmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the Organism | Q35084574 | ||
| Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea | Q35107269 | ||
| Meconium microbiome analysis identifies bacteria correlated with premature birth | Q35116563 | ||
| Shifting the paradigm from pathogens to pathobiome: new concepts in the light of meta-omics. | Q35122256 | ||
| The placenta harbors a unique microbiome | Q35171983 | ||
| Gut microbiota, immunity, and disease: a complex relationship | Q35195785 | ||
| Modulation of immune development and function by intestinal microbiota. | Q35235355 | ||
| The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes | Q35557877 | ||
| Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections | Q35575533 | ||
| Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota | Q35576364 | ||
| Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways | Q35582657 | ||
| Brain-gut-microbe communication in health and disease | Q35597520 | ||
| Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods | Q35617258 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immune system | Q1059 |
| infectious disease | Q18123741 | ||
| neoplasm | Q1216998 | ||
| immune disorder | Q3843811 | ||
| disease susceptibility | Q65534164 | ||
| body constitution | Q66771588 | ||
| hemic and immune systems | Q70202933 | ||
| P304 | page(s) | 1830 | |
| P577 | publication date | 2018-08-15 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer | |
| P478 | volume | 9 |
| Q93073764 | Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain |
| Q98564346 | Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation |
| Q64284501 | Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study |
| Q93006506 | Associations of Breast Milk Microbiota, Immune Factors, and Fatty Acids in the Rat Mother-Offspring Pair |
| Q91690213 | Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression |
| Q89965334 | Distinct Types of Gut Microbiota Dysbiosis in Hospitalized Gastroenterological Patients Are Disease Non-related and Characterized With the Predominance of Either Enterobacteriaceae or Enterococcus |
| Q100758619 | Dysbiosis of the gut microbiota maybe exacerbate orf pathology by promoting inflammatory immune responses |
| Q99551244 | Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach |
| Q97541115 | Gut microbiome, big data and machine learning to promote precision medicine for cancer |
| Q89548582 | Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide |
| Q91711899 | Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis |
| Q92190760 | Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma |
| Q89497694 | Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research |
| Q94672157 | Linking gut microbiota with the human diseases |
| Q92157568 | Metabolism at the centre of the host-microbe relationship |
| Q94570952 | Microphysiological Engineering of Immune Responses in Intestinal Inflammation |
| Q99238206 | NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers? |
| Q90641575 | Pre-existing heterologous T-cell immunity and neoantigen immunogenicity |
| Q95630996 | Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity |
| Q58608329 | Rationale of Probiotic Supplementation during Pregnancy and Neonatal Period |
| Q89848447 | Reconciling Hygiene and Cleanliness: A New Perspective from Human Microbiome |
| Q93151253 | Reversal of ciprofloxacin-induced testosterone reduction by probiotic microbes in mouse testes |
| Q101038687 | Stratified layer analysis reveals intrinsic leptin stimulates cryptal mesenchymal cells for controlling mucosal inflammation |
| Q99605605 | The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance |
| Q64063980 | The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid Malignancies |
| Q92711908 | The composition of the perinatal intestinal microbiota in horse |
| Q91034340 | The microbiota-gut-brain axis: A promising avenue to foster healthy developmental outcomes |
| Q97093856 | Vitamin D and the Host-Gut Microbiome: A Brief Overview |
Search more.